RedHill Biopharma Finalizes Agreement to Bolster Finances

TipRanks34minutes ago

Express News | Redhill Biopharma Terminates Agreement With Movantik Acquisition, Valinor Pharma, And Hcr Redhill, And Received ~$9.9M In Cash And Gained Full Control Over An Additional $0.74M Currently Held In Restricted Account

Benzinga47minutes ago

RedHill Terminates License Agreement With Cosmo Technologies

Seeking AlphaJul 9 08:50 ET

RedHill Biopharma Terminates License Agreement For Aemcolo, A Treatment For Traveler's Diarrhea, Will Be Officially Terminated On October 8, 2024

RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the mutual decision with Cosmo Technologies Ltd. ("Cosmo") to voluntary

BenzingaJul 9 08:12 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersNexalin Technology (NASDAQ:NXL) shares rose 55.8% to $1.62 during Tuesday's after-market session. The market value of their outstanding shares is at $12.0 million. Dynatronics (NASDAQ:DYNT) sto

BenzingaJun 18 16:31 ET

RedHill Biopharma Has Received A Notice Of Allowance For Its U.S. Patent Application 17/900,235 Titled "BIOMARKERS OF CORONAVIRUS PNEUMONIA (FOR TREATING CORONAVIRUS INFECTION OR PREVENTING DISEASES CAUSED BY CORONAVIRUS INFECTION)"

RedHill Biopharma Has Received A Notice Of Allowance For Its U.S. Patent Application 17/900,235 Titled "BIOMARKERS OF CORONAVIRUS PNEUMONIA (FOR TREATING CORONAVIRUS INFECTION OR PREVENTING DISEASES C

BenzingaJun 18 15:58 ET